Orange Book product · Brand (NDA)
AMICAR
AMINOCAPROIC ACID
At a glance
Jun 24, 2004
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 24, 2004
22 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
AMINOCAPROIC ACID
Strength
1GM
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 015197
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1982AMINOCAPROIC ACIDBrand (NDA)
NDA 018590 · BAXTER HLTHCARE
- —AMICARBrand (NDA)
NDA 015229 · EPIC PHARMA LLC
- —AMICARBrand (NDA)
NDA 015230 · HIKMA
- 2025AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 215374 · ZENARA
- 2025AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213216 · SCIEGEN PHARMS
- 2024AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 215100 · MSN
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213213 · SUNNY
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 212938 · MSN
- 2023AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 214458 · TARO
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 216464 · ANNORA PHARMA
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 216804 · AUROBINDO PHARMA
- 2022AMINOCAPROIC ACIDGeneric (ANDA)
ANDA 213944 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
